BIIB
Price
$131.14
Change
+$1.35 (+1.04%)
Updated
Jun 2 closing price
Capitalization
31.34B
50 days until earnings call
SCLX
Price
$4.82
Change
-$0.09 (-1.83%)
Updated
Jun 3, 10:40 AM (EDT)
Capitalization
165.55M
Interact to see
Advertisement

BIIB vs SCLX

Header iconBIIB vs SCLX Comparison
Open Charts BIIB vs SCLXBanner chart's image
Biogen
Price$131.14
Change+$1.35 (+1.04%)
Volume$1.87M
Capitalization31.34B
Scilex Holding
Price$4.82
Change-$0.09 (-1.83%)
Volume$100
Capitalization165.55M
BIIB vs SCLX Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIIB vs. SCLX commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and SCLX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (BIIB: $131.14 vs. SCLX: $4.91)
Brand notoriety: BIIB: Notable vs. SCLX: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 104% vs. SCLX: 65%
Market capitalization -- BIIB: $31.34B vs. SCLX: $165.55M
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $165.55M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 0 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • BIIB’s FA Score: 0 green, 5 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, SCLX is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 5 TA indicator(s) are bullish while SCLX’s TA Score has 4 bullish TA indicator(s).

  • BIIB’s TA Score: 5 bullish, 3 bearish.
  • SCLX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than SCLX.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а +4.24% price change this week, while SCLX (@Pharmaceuticals: Major) price change was +7.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.97%. For the same industry, the average monthly price growth was +1.52%, and the average quarterly price growth was +2.73%.

Reported Earning Dates

BIIB is expected to report earnings on Jul 23, 2025.

SCLX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.97% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($31.3B) has a higher market cap than SCLX($166M). BIIB YTD gains are higher at: -14.243 vs. SCLX (-67.100). BIIB has higher annual earnings (EBITDA): 2.04B vs. SCLX (-109.1M). BIIB has more cash in the bank: 1.05B vs. SCLX (3.92M). SCLX has less debt than BIIB: SCLX (128M) vs BIIB (7.34B). BIIB has higher revenues than SCLX: BIIB (9.84B) vs SCLX (46.7M).
BIIBSCLXBIIB / SCLX
Capitalization31.3B166M18,855%
EBITDA2.04B-109.1M-1,868%
Gain YTD-14.243-67.10021%
P/E Ratio26.95N/A-
Revenue9.84B46.7M21,062%
Total Cash1.05B3.92M26,779%
Total Debt7.34B128M5,733%
FUNDAMENTALS RATINGS
BIIB: Fundamental Ratings
BIIB
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIIBSCLX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
49%
Momentum
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
46%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
42%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
31%
Advances
ODDS (%)
Bullish Trend 15 days ago
53%
Bullish Trend 6 days ago
69%
Declines
ODDS (%)
Bearish Trend 12 days ago
70%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
39%
Aroon
ODDS (%)
Bullish Trend 1 day ago
41%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FATE1.300.09
+7.44%
Fate Therapeutics
XAGE3.27-0.03
-0.91%
Longevity Health Holdings Inc
FND70.09-1.60
-2.23%
Floor & Decor Holdings
ICFI82.01-3.91
-4.55%
ICF International
NOVA0.20-0.02
-8.74%
Sunnova Energy International

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+1.04%
AMGN - BIIB
52%
Loosely correlated
+0.10%
PFE - BIIB
49%
Loosely correlated
-0.13%
NVS - BIIB
47%
Loosely correlated
+0.81%
SNY - BIIB
43%
Loosely correlated
-0.36%
AZN - BIIB
39%
Loosely correlated
-1.24%
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and AMRN have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and AMRN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-4.10%
AMRN - SCLX
20%
Poorly correlated
+1.29%
BIIB - SCLX
20%
Poorly correlated
+1.04%
ABBV - SCLX
11%
Poorly correlated
+0.47%
RHHVF - SCLX
8%
Poorly correlated
+0.88%
NVS - SCLX
6%
Poorly correlated
+0.81%
More